Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL

NCT02784834 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped lack of funding

Conditions

Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma

Interventions

DRUG: dimethyl fumarate

Sponsor

Michael Choi

Collaborators

[object Object]